By Mill Chart
Last update: Jun 14, 2024
Exploring Growth Potential: NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) and Its Base Formation. Growth investors seek promising revenue and EPS growth, and NEUROCRINE BIOSCIENCES INC has come under our scrutiny for potential growth investing. While it's crucial to do your own research, we've detected NEUROCRINE BIOSCIENCES INC on our screen for growth with base formation, suggesting it merits a closer look.
ChartMill assigns a Growth Rating to every stock. This score ranges from 0 to 10 and evaluates the different growth aspects like EPS and Revenue, both in the past as in the future. NASDAQ:NBIX scores a 9 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NASDAQ:NBIX, the assigned 7 reflects its health status:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:NBIX was assigned a score of 9 for profitability:
In addition to the Technical Rating, ChartMill provides a Setup Rating for each stock. This rating, ranging from 0 to 10, assesses the extent of consolidation in the stock based on multiple short-term technical indicators. Currently, NASDAQ:NBIX has a 8 as its setup rating:
Although the technical rating is only medium, NBIX does present a nice setup opportunity. Prices have been consolidating lately and the volatility has been reduced. There is a support zone below the current price at 134.93, a Stop Loss order could be placed below this zone.
More Strong Growth stocks can be found in our Strong Growth screener.
Our latest full fundamental report of NBIX contains the most current fundamental analsysis.
Check the latest full technical report of NBIX for a complete technical analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
101.38
+1.28 (+1.28%)
Find more stocks in the Stock Screener
Based on Fundamental Analysis it can be said that NASDAQ:NBIX is a growth stock which is not overvalued.
Discover NEUROCRINE BIOSCIENCES INC, an undervalued stock. NASDAQ:NBIX showcases solid financial health and profitability while maintaining an appealing valuation.